Carrelizumab (PD-1) Combined With Chemotherapy in Neoadjuvant Treatment of Locally Advanced Gastric Cancer

NCT05545436 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Gastric Cancer

Interventions

DRUG: Camrelizumab + SOX (oxaliplatin + Teggio) /XELOX (oxaliplatin + capecitabine )

Sponsor

Third Affiliated Hospital, Sun Yat-Sen University

Collaborators

[object Object]